A Pilot Study of Voraxaze (Glucarpidase) in Patients With Central Nervous System Lymphoma
Phase of Trial: Phase 0
Latest Information Update: 20 Nov 2018
At a glance
- Drugs Glucarpidase (Primary) ; Folinic acid; Methotrexate; Rituximab
- Indications Chemotherapy-induced damage
- Focus Pharmacokinetics
- 14 Nov 2018 Status changed from not yet recruiting to recruiting.
- 07 Nov 2018 Planned initiation date changed from 1 Oct 2018 to 1 Nov 2018.
- 04 Oct 2018 New trial record